Senate President Karen Spilka nominates Lykan Bioscience for Manufacturer of the Year
5th Annual Manufacturing Excellence Award recognizes work of Hopkinton company
(BOSTON – 07/21/2020) On October 14, 2020, Massachusetts State Senate President Karen E. Spilka
nominated Hopkinton-based Lykan Bioscience for a ‘Manufacturer of the Year’ award, part of a series of
awards given by the state legislature’s Manufacturing Caucus to companies across the state to promote
“Made in Massachusetts.” These awards recognize companies across the Commonwealth which support
outstanding innovation in the field of manufacturing.
This year, the caucus is acknowledging the many manufacturers who have
demonstrated an unprecedented response to the needs of Massachusetts
during the COVID-19 pandemic. Lykan Bioscience was selected from
among many outstanding manufacturing firms located in the Second
Middlesex and Norfolk district, which Senate President Spilka represents in
the State House.
The company offers manufacturing services for autologous and allogeneic
cell-based therapies for individuals with serious health conditions, such as
cancer. During the pandemic, the company built a 64,000 sq. ft. purpose-built
manufacturing facility in Hopkinton, which will create more than 150 new jobs by 2022. The company is
now online and is equipped to manufacture advanced therapy medicines for thousands of patients with
unmet needs.
“Biotech is an exciting field and one of our strengths in Massachusetts–particularly in the MetroWest area.
As the Chair of the Biotech Legislative Caucus, I sought to bring the industry to the center of our
conversations on Massachusetts’ economy, environment and health.” stated Senate President Karen E.
Spilka (D-Ashland). “I applaud Lykan Bioscience’s work, and I am grateful to Senator Eric Lesser and
Representative Jeff Roy, Joint-Chairs of the Manufacturing Caucus, for extending this opportunity to me
to recognize one of our rising stars.”
“We are honored to have been nominated for this award and thrilled to have our brand-new facility available
to meet clients’ demand,” said Lykan Bioscience CEO Anthony Rotunno. “Being based in MA allows
us to be able to efficiently and cost-effectively supply treatments to so many patients, starting in the
Northeast region. As a company, offering treatments to as many patients and saving as many lives as
possible, is our passion.”
A ceremony to confer this and other manufacturing awards took place on Tuesday, October 27, 2020
at 11:00 AM, in a virtual forum.